The widespread usage of
plastic products in human life has led to extensive exposure to
plasticizers and resulted in serious health problems for humans, which has become a focus of toxicology research in the world. We aimed to explore the potential mechanism of liver
insulin resistance induced by di(2-ethylhexyl)
phthalate (
DEHP) and working on a novel treatment to alleviate
insulin resistance caused by excessive exposure to
DEHP. For this purpose, in vivo and in vitro experiments were conducted, and the pivotal factors in the
insulin signaling pathway were analyzed. In vivo study showed
DEHP could lead to liver injury and
insulin resistance.
DEHP could break the balance of oxidative stress and cause accumulation of inflammatory factors. Genomics and proteomics experiment results revealed that
DEHP could inhibit the
mRNA and
protein expression of
insulin receptor,
insulin receptor substrate, PI3K/Akt/mTOR, and
glucose transporter 4. Nevertheless, the liver
insulin resistance induced by
DEHP could be reversed by
Verapamil (
thioredoxin interacting
protein (TXNIP) inhibitor). Thus, we confirmed that
DEHP caused
insulin resistance by affecting the TXNIP in liver, further damaging the conduction of
insulin signaling pathway. Therefore, adding
Verapamil to the treatment of patients with
insulin resistance due to
plasticizers might be more effective.